Skip to content
MARKETS / NYSE / OHI
NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

Omega Healthcare Investors Inc. OHI

18 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.2B
▲ 13.2% YoY
$590.2M
▲ 45.2% YoY
$188.2M
▲ 2007.0% YoY
In brief

What this company does

Omega Healthcare Investors, Inc. invests in healthcare-related real estate properties located in the United States, the United Kingdom and Canada. Its investment portfolio primarily consists of skilled nursing facilities, assisted living facilities, including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities and continuing care retirement communities. As of December 31, 2025, its portfolio of consolidated real estate investments included 1,027 operating healthcare facilities operated by 89 third-party operators or managers in 42 states, Washington, D.C., the U.K. and Bailiwick of Jersey. As of February 1, 2026, it had 69 employees, none of whom is subject to a collective bargaining agreement. Substantially all of its leases are triple-net operating leases, which require the operator to pay rent and all additional charges incurred in operating the leased facility. Omega is structured as an umbrella partnership REIT under which its assets are owned, and its operations are conducted, through its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership. Omega became a publicly traded company listed on the New York Stock Exchange in 1992.

Written from the business description in OMEGA HEALTHCARE INVESTORS, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 9 February 2026. Every sentence was checked against that document before publication.

Growth
USD 1.2B
Revenue, FY2025 · full 18-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.2 · Net income 0.6
0.4B0.8B2008201120142017202020232025
Compound annual growth
+10.7%
+5.9%
+4.8%
+10.7%
+16.7%
+2.5%
+22.6%
+4.2%
+0.0%
+0.0%
+2.1%
+0.2%
+5.0%
+8.1%
+12.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +5.9% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
51 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 52.5% · Net 51.2%
20%40%60%2008201120142017202020232025
ROE
FY2025 · ROE 12.1%
5%10%15%2008201120142017202020232025

Each USD of equity produced 12 cents of profit this year.

Cash & shareholders
USD 780.4M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 188.2
250.0M500.0M-200.0M2008201120142017202020232025
Net buybacks $M Dividends $M
FY2025 · Dividends 780.4 · Net buybacks —
400MDividendsNet buybacks2008201120142017202020232025

USD 780.4M in dividends — 132% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 10.0B
EquityUSD 5.2B
CashUSD 27.0M
Gross debtUSD 4.3B
Net debtUSD 4.2B

Net debt stands at 82% of equity.

The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011201020092008
Revenue $B1.21.10.90.91.10.90.90.90.90.90.70.50.40.40.30.30.20.2
Operating income $B0.60.40.3···0.60.50.30.60.40.30.30.20.10.10.10.1
EBITDA $B0.90.70.6···0.90.80.60.80.60.50.40.30.20.20.20.1
Income tax $B0.00.00.00.00.00.00.00.00.00.00.0····0.00.0−0.0
Net income $B0.60.40.20.40.40.20.40.30.10.40.20.20.20.10.10.10.10.1
Free cash flow $B0.20.00.40.40.10.6·0.40.2−0.30.20.20.2−0.20.1−0.2−0.0−0.0
EPS, diluted $1.941.551.001.801.750.701.581.400.511.901.291.741.461.120.460.520.870.94
Dividend / sh $2.682.682.682.682.682.682.652.642.542.362.182.021.861.691.551.371.201.19
Payout %132169266144149374160180479118154117126151308238133126
ROE %12.110.06.711.711.14.19.38.42.810.19.116.414.912.85.66.39.99.9
Shares out B0.300.280.250.230.240.230.230.200.200.200.190.130.120.110.100.100.090.08

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 53 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 4 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityReal Estate Investment Trusts
Listed onNYSE
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2008

Share this section

Download image